Ir para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Palavra solta
Título
Autor
Assunto
Área/Cota
ISBN/ISSN
Tag
Pesquisar
Avançada
IN PATIENTS WITH ANKYLOSING SP...
Citar
Enviar por SMS
Enviar por email
Imprimir
Exportar registo
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Permanent link
IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS), ADALIMUMAB IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (Ps) AND PREVENTS ANTERIOR UVEITIS (AU) FLARES
Detalhes bibliográficos
Main Authors:
Wordsworth, P
,
Rudwaleit, M
,
Claudepierre, P
,
Loza, E
,
Olivieri, I
,
Wong, R
,
Oezer, U
,
Kary, S
,
Kupper, H
Formato:
Conference item
Publicado em:
2009
Exemplares
Descrição
Registos relacionados
Registo fonte
Registos relacionados
Adalimumab (HUMIRA (R)) improves inflammatory bowel disease (IBD) and psoriasis (Ps) and prevents anterior uveitis (AU) flares in patients with Ankylosing spondylitis (AS)
Por: Rudwaleit, M, et al.
Publicado em: (2008)
Predictors of good clinical response (BASDAI 50 or ASAS partial remission) in 1,250 patients treated with adalimumab (humira (R)) for active ankylosing spondylitis (AS)
Por: Rudwaleit, M, et al.
Publicado em: (2008)
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis.
Por: Rudwaleit, M, et al.
Publicado em: (2009)
Adalimumab is effective and well-tolerated in patients with ankylosing spondylitis (AS) in day-to-day clinical practice - Results from rhapsody
Por: Wordsworth, P, et al.
Publicado em: (2008)
Efficacy of adalimumab in uveitis in patients with ankylosing spondylitis
Por: Shandor Fedorovich Erdes
Publicado em: (2012-03-01)